Paediatric insulin injection technique: The softer side

Sanjay Kalra1, Asma Al Deeb2, Mudita Dhingra3

  • 1Department of Endocrinology, Bharti Hospital, Karnal, India.

Insights

This study details best practices for pediatric insulin injections, considering children's unique needs for a positive diabetes management experience. It emphasizes tailoring techniques for a healthier, happier injection process for young patients.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Management
  • Patient Education

Background:

  • Insulin therapy is crucial for managing pediatric diabetes.
  • Standard injection techniques may not fully address the unique needs of children and adolescents.
  • A positive injection experience is vital for adherence and long-term health outcomes.

Purpose of the Study:

  • To highlight unique aspects of insulin injection technique in the pediatric population.
  • To correlate child-specific characteristics with optimal injection practices.
  • To promote a positive and healthy insulin injection experience for children and adolescents with diabetes.

Main Methods:

  • Review of anatomical, neurodevelopmental, and psychosocial characteristics of pediatric age groups.
  • Correlation of these characteristics with established insulin delivery guidelines.
  • Identification of 'best practices' for pediatric insulin injection technique.

Main Results:

  • Paediatric insulin injection technique requires consideration of age-specific anatomical, developmental, and psychosocial factors.
  • Tailored approaches can lead to improved injection experiences for children.
  • The 'softer side' of technique complements existing technical guidelines.

Conclusions:

  • Optimizing insulin injection technique in children necessitates a holistic approach, integrating developmental and psychosocial considerations.
  • Further research is encouraged to address the specific challenges faced by young people with diabetes.
  • Implementing these best practices can enhance the overall well-being and diabetes management of pediatric patients.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.0K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.3K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
758
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.4K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
788
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.6K